European Geriatric Medicine

, Volume 9, Issue 2, pp 175–181 | Cite as

Association of orthogeriatric services with long-term mortality in patients with hip fracture

  • Maria-Jesús Pueyo-Sánchez
  • M. Larrosa
  • X. Surís
  • P. Sánchez-Ferrin
  • I. Bullich-Marin
  • E. Frigola-Capell
  • Vicente Ortún
Research Paper



To assess the impact of the comprehensive orthogeriatric care model (OGM) on 2-year survival, length of stay (LOS), discharges to nursing homes, and antiosteoporotic treatment (AOT) in patients with hip fracture.


Retrospective cohort study. Hospitals were classified as OGM if the patient was cared for in a comprehensive orthogeriatric unit. We included data from patients ≥ 65 years old discharged between 2012 and 2013. The main outcome was 12- and 24-month mortality. The variables collected were sex, type of fracture, comorbidities, AOT, LOS, and discharge to nursing homes. Survival analysis was performed with Kaplan–Meier method and comparison with Mantel–Haenszel test. Factors associated with death were determined by logistic regression.


First admissions in the 12 (out of 32) hospitals with OGM were 3580 of 9215 (38.8%). Patients in OGM had more comorbidities and discharges to nursing homes, shorter LOS, and less prescription of AOT. Two years after the admission the deceased patients were 3000 (32.6%). The survival was lower in males (p < 0.001), in the older age groups (p < 0.001), and in patients with Charlson > 1 (p < 0.001). Factors associated with increased risk of death at 12 and 24 months (logistic regression) were male gender, age and Charlson > 1, while care in the OGM decreased the risk. OGM benefited more patients > 80 years and those with Charlson < 1.


Patients admitted in OGM have shorter stays, more discharges to nursing homes, lower prescription of AOT, and better 12- and 24-month survival adjusted by sex, age, and comorbidities compared to non-OGM care.


Hip fracture Survival analysis Orthogeriatrics Antiosteoporotic treatment 


Author’s contribution

MJP, ML, XS, PSF, and IB have made substantial contributions to the design, acquisition of data, analysis and interpretation of results. MJP has drafted the manuscript. ML, XS, PSF, IB, EFC, and VO have revised the article critically for important intellectual content. All the authors have revised the final version of the manuscript.


This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the Department of Health of Catalonia and with the 1964 Helsinki declaration and its later amendements or comparable ethical standards.

Informed consent

All the data were anonymised and used in an aggregated manner. So the informed consent was unnecessary.


  1. 1.
    Pueyo-Sánchez MJ, Larrosa M, Surís X, Casado E, Auleda J, Fusté J, Ortún V (2017) Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003–14. Age Ageing 46:324–328PubMedGoogle Scholar
  2. 2.
    Observatori del Sistema de Salut de Catalunya (2015) Central de Resultats. Processos. La fractura de coll de fèmur en població de 65 anys o més. Dades 2014. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya. Departament de Salut. Generalitat de Catalunya. Last Access 12 May 2017
  3. 3.
    Cruz Jentoft AJ, Serra Rexach JA, Lázaro del Nogal M et al (1994) The efficacy of geriatric consultation in elderly patients admitted to traumatology services. An Med Intern (Madrid) II:273–277Google Scholar
  4. 4.
    González-Montalvo JI, Gotor Pérez P, Martin Vega A et al (2011) The acute orthogeriatric unit. Assessment of its effect on the clinical course of patients with hip fractures and an estimate of its financial impact. Rev Esp Geriatr Gerontol 46(4):193–199CrossRefPubMedGoogle Scholar
  5. 5.
    Sabharwal S, Wilson H (2015) Orthogeriatrics in the management of frail older patients with a fragility fracture. Osteoporos Int 26:2387–2399CrossRefPubMedGoogle Scholar
  6. 6.
    Grigoryan KV, Javedan H, Rudolph JL (2014) Ortho-geriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma 28(3):e49–e55CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Buecking B, Timmesfeld N, Riem S et al (2013) Early orthogeriatric treatment of trauma in the elderly—a systematic review and metaanalysis. Dtsch Arztebl Int 110(15):255–262. PubMedPubMedCentralGoogle Scholar
  8. 8.
    Suhm N, Kaelin R, Studer P, Wang Q, Kressig RW, Rikli D et al (2014) Orthogeriatric care pathway: a prospective survey of impact on length of stay, mortality and institutionalisation. Arch Orthop Trauma Surg 134:1261–1269CrossRefPubMedGoogle Scholar
  9. 9.
    Middleton M, Wan B, da Assunçao R (2016) Improving hip fracture outcomes with integrated orthogeriatric care: a comparison between two accepted orthogeriatric models. Age Ageing. PubMedCentralGoogle Scholar
  10. 10.
    Heltne M, Saltvedt I, Lydersen S, Prestmo A, Sletvold O (2017) Spigset O Patterns of drug prescriptions in an orthogeriatric ward as compared to orthopaedic ward: results from de Trondheim Hip Fracture Trial—a randomised clinical trial. Eur J Clin Pharmacol 73:937–947CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Friedman SM, Mendelson DA, Bingham KW, Kates SL (2009) Impact of a comanaged Geriatric Fracture Center on short-term hip fracture outcomes. Arch Intern Med 169:1712–1717CrossRefPubMedGoogle Scholar
  12. 12.
    Leal J, Gray AM, Hawley S et al (2016) Cost-effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: a population-based study. J Bone Miner Res. Google Scholar
  13. 13.
    Ginsberg G, Adunsky A, Rasooly I (2013) A cost-utility analysis of a comprehensive orthogeriatric care for hip fracture patients, compared with standard of care treatment. Hip Int 23(6):570–575CrossRefPubMedGoogle Scholar
  14. 14.
    Vidan M, Serra JA, Moreno C, Riquelme G, Ortiz J (2005) Efficacy of a comprehensive geriatric intervention in older patients hospitalized for hip fractures: a randomized controlled trial. J Am Geriatr Soc 53:1476–1482CrossRefPubMedGoogle Scholar
  15. 15.
    Zeltzer J, Mitchell RJ, Toson B, Harris IA, Ahmad L, Close J (2014) Orthogeriatric services associated with lower 30-day mortality for older patients who undergo surgery for hip fracture. Med J Aust 201(7):409–411CrossRefPubMedGoogle Scholar
  16. 16.
    Stenqvist C, Madsen CM, Riis T, Jorgensen HL, Duus BR, Lauritzen JB et al (2016) Orthogeriatric services reduces mortality in patients with hip fracture. Geriatr Orthop Surg Rehabil 7(2):67–73CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Gosch M, Hoffmann-Weltin Y, Roth T, Blauth M, Nicholas JA, Kammerlander C (2016) Orthogeriatric co-management improves the outcom of long-term care residents with fragility fractures. Arch Orthop Trauma Surg 136(10):1403–1409CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Folbert EC, Hegeman JH, Vermeer M et al (2017) Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment. Osteoporos Int 28(1):269–277CrossRefPubMedGoogle Scholar
  19. 19.
    Hawley S, Javaid MK, Prieto-Alhambra D, Lippett J, Sheard S, Arden NK et al (2016) Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing 45(2):236–242CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Henderson CY, Shanahan E, Butler A, Lenehan B, O’Connor M, Lyons D et al (2017) Dedicated orthogeriatric service reduces hip fracture mortality. Ir J Med Sci 186(1):179–184CrossRefPubMedGoogle Scholar
  21. 21.
  22. 22.
    Generalitat of Catalonia (2006) Ministry of Health. Master Plan for Health and Social Care. Barcelona.   Accessed 12 Feb 2016
  23. 23.
    Kates SL, O’Malley N, Friedman SM, Mendelson DA (2012) Barriers to implementation of an organized geriatric fracture program. Geriatr Orthoped Surg Rehabil 3(1):8–16CrossRefGoogle Scholar
  24. 24.
    Meessen JM, Pisani S, Gambino ML, Bonarrigo D, van Schoor NM, Fozzato S, Cherubino P, Surace MF (2014) Assessment of mortality risk in elderly patients after proximal femoral fracture. Orthopedics 37(2):e194–e200CrossRefPubMedGoogle Scholar
  25. 25.
    Trombetti A, Herrmann F, Hoffmeyer P, Schurch MA, Bonjour JP, Rizzoli R (2002) Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 13:731–737CrossRefPubMedGoogle Scholar
  26. 26.
    Holviq K, Ranhoff AH, Martinsen MI, Soldheim LF (2010) Predictors of mortality in older hip fracture inpatients admitted to an orthogeriatric unit in Oslo, Norway. J Aging Health 22(8):1114–1131CrossRefGoogle Scholar
  27. 27.
    Henderson CY, Ryan JP (2015) Predicting mortality following hip fracture: an analysis of comorbidities and complications. Ir J Med Sci 184:667–671CrossRefPubMedGoogle Scholar
  28. 28.
    Prestmo A, Hagen G, Sletvold O, Helbostad JL, Thingstad P, Taraldsen K et al (2015) Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial. Lancet 25(385):1623–1633CrossRefGoogle Scholar
  29. 29.
    Prestmo A, Saltveldt I, Helbostad JL, Taraldsen K, Thingstad P, Lydersen S et al (2016) Who benefits from orthogeriatric treatment? Results from the Trondheim hip-fracture trial. BMC Geriatr 16:49CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Watne LO, Torgbersen AC, Conroy S, Engedal K, Frihagen F, Hjorthaug GA et al (2014) The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial). BMC Med 12(1):63CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Sáez López P, González Montalvo JI, Alarcón T, Madruga F, Barcena A (2006) Optimization of medical treatment in a geriatric patient with hip fracture. Influence of the consulting team. Rev Esp Geriatr Gerontol 41:85–91CrossRefGoogle Scholar
  32. 32.
    Kim SC, Kim MS, Sanfélix-Gimeno G et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519–526CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Klop C, Gibson-Smith D, Elders PJM et al (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010. Osteoporos Int 26:1919–1928CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Hawley S, Leal J, Delmestri A et al (2016) Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and wales: an interrupted time-series analysis. J Bone Miner Res. Google Scholar
  35. 35.
    Peng J, Liu Y, Chen L et al (2016) Bisphosphonates can prevent hip fracture and redice the mortality in osteoporotic patient with hip fracture: a meta-analysis. Pak J Med Sci 32(2):499–504PubMedPubMedCentralGoogle Scholar
  36. 36.
    Beaupre LA, Mirrish DA, Maksymowych WP et al (2011) Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int 22(3):983–991CrossRefPubMedGoogle Scholar
  37. 37.
    Índex de Qualitat de la Prescripció Farmacèutica (IQF). Versió (2015) Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya. Servei Català de la Salut. Departament de Salut. Generalitat de Catalunya; 2015. (Programa d’Innovació i Suport a l’Àmbit del Medicament;01/2015). Last Access 27 Dec 2017
  38. 38.
    Dubljanin-Rapopovic E, Markovic-Denic L, Marinkovic J, Nedeljjovic U, Bumbasirevic M (2013) Does early functional outcome predict 1-year mortality in elderly patients with hip fracture? Clin Orthop Relat Res 471(8):2703–2710CrossRefGoogle Scholar

Copyright information

© European Geriatric Medicine Society 2018

Authors and Affiliations

  1. 1.Department of HealthMaster Plan of Musculoskeletal DiseasesBarcelonaSpain
  2. 2.Department of Experimental and Health SciencesPompeu Fabra UniversityBarcelonaSpain
  3. 3.Rheumatology DepartmentParc Taulí Hospital UniversitariSabadellSpain
  4. 4.Rheumatology DepartmentHospital General de GranollersGranollersSpain
  5. 5.School of Medicine and Health SciencesInternational University of CataloniaSant Cugat del VallèsSpain
  6. 6.Department of HealthMaster Plan of Social and Health CareBarcelonaSpain
  7. 7.Department of EconomicsPompeu Fabra UniversityBarcelonaSpain
  8. 8.Jordi Gol Institute for Research in Primary CareIDIAP Jordi GolBarcelonaSpain

Personalised recommendations